Dr. Strasswimmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2605 W Atlantic Ave
D204
Delray Beach, FL 33445Phone+1 561-819-5822Fax+1 561-819-5823
Summary
- Principal Investigator for Clinical Trials in Dermatology Oncology from Phase 1 to Phase 4
Education & Training
- Mohs College- Dr GrandeFellowship, Micrographic Surgery and Dermatologic Oncology, 2004 - 2005
- Harvard Medical SchoolFellowship, Clinical Applications of Laser, 2003 - 2004
- Yale-New Haven Medical CenterResidency, Dermatology, 2000 - 2003
- Cambridge Health AllianceInternship, Transitional Year, 1999 - 2000
- Tufts University School of MedicineClass of 1999
Certifications & Licensure
- CO State Medical License 2020 - 2025
- FL State Medical License 2005 - 2025
- NC State Medical License 2021 - 2025
- SC State Medical License 2020 - 2025
- MA State Medical License 2003 - 2006
- American Board of Dermatology Dermatology
- American College of Mohs SurgeryFellow, American College fo Mohs Micrographic Surgery and Cutaneous Oncology
Awards, Honors, & Recognition
- Melanoma Program, Founding Medical Director Lynn Cancer Insitute, Boca Raton, FL, 2009-2017
- Gulfstream FL-Palm Beach Castle Connolly, 2014
- Fellow (FAAD) American Academy of Dermatology
- Join now to see all
Clinical Trials
- Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). Start of enrollment: 2018 Sep 25
- CemiplimAb Survivorship Epidemiology Start of enrollment: 2019 Jun 27
- Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma Start of enrollment: 2019 Apr 11
Publications & Presentations
PubMed
- 404 citationsSMN oligomerization defect correlates with spinal muscular atrophy severity.Christian L. Lorson, John Strasswimmer, Jun Mei Yao, James D. Baleja, E. Hahnen
Nature Genetics. 1998-05-01 - 566 citationsThe Survival Motor Neuron Protein in Spinal Muscular AtrophyDaniel D. Coovert, Thanh Le, Patricia E. McAndrew, John Strasswimmer, Thomas O. Crawford
Human Molecular Genetics. 1997-08-01 - 118 citationsAdverse Events Associated With Mohs Micrographic Surgery: Multicenter Prospective Cohort Study of 20 821 Cases at 23 CentersMurad Alam, Omer Ibrahim, Michael Nodzenski, John Strasswimmer, Shang I Brian Jiang
JAMA Dermatology. 2013-12-01
Lectures
- Management of large cutaneous tumors37th Nordic Plastic Surgery Meeting Copenhagen, Denmark - 6/14/2018
- Novel Therapies for BCC and SCC of Skin and Merkel Cell Carcinoma14th Miami Cancer Meeting
- Humanitarian work in America: A Dermatologist's RoleAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
- Join now to see all
Press Mentions
- Dermatology Associates of the Palm BeachesJuly 22nd, 2022
- Reviewers' List December 2020August 12th, 2020
- Potentially Faster and More Accurate Mode of Cancer Treatment with New Laser TechnologyFebruary 12th, 2015
- Join now to see all
Research History
- Principal Investigator: Pilot exploratory study of multifunctional optical coherence tomography (OCT) for dermatology and cancerWellman Center for Photomedicine, Massachusetts General Hospital. Translational research project to bring new OCT to clinical application2002 - 2005
Professional Memberships
- Fellow
- American College of Mohs Surgery and Cutaneous OncologyFellow
- Fellow
- Rotary InternationalMember
- Rotary Fellowship of DoctorsMember
Other Languages
- Spanish, French, German
Industry Relationships
- Site Specific Principal Investigator, Regeneron PharmaceuticalsPhase 1 Clinical TrialDisclosure: Research Grant Support2020 - Present
- Consultant and Speaker, Sanofi GenzymeConsultant and SpeakerDisclosure: Honoraria2019 - Present
- Site Principal Investigator, Regeneron PharmaceuticalsPhase Four Clinical TrialDisclosure: Research Grant Support2019 - Present
- Consultant and Speaker, Sun Pharmaceuticals, Inc.ConsultantDisclosure: Consultant Fees2015 - 2020
- Consultant and Speaker, Genentech Roche Inc.Consultant and SpeakerDisclosure: Honoraria2012 - 2020
- Site Principal Investigator, Novartis PharmaRetospective review of use of vismodegibDisclosure: Research Grant Support2014 - 2015
External Links
- Dermatology Practicehttps://www.strasswimmer.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: